Certified by Founder Lodge
Renibus Therapeutics Inc
United States - Southlake, Texas
START UP
1 Disclosed Funding Rounds $47,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Renibus is a clinical stage biopharmaceutical company dedicated to treating, improving and extending patients’ lives by developing breakthrough products to prevent disease progression, improv
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| July, 19 ,2023 | Series B | $47,000,000 | |
| September, 13 ,2023 | Series B | Undisclosed Amount |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Voio | $8,600,000 | (Nov 21, 2025)
Stuut | $29,500,000 | (Nov 21, 2025)
Made Card | $8,000,000 | (Nov 21, 2025)
Revenium | $13,500,000 | (Nov 21, 2025)
EQORE | $1,700,000 | (Nov 21, 2025)